ALEMBIC
Quarterly Results Analysis [Mar2025]
ALEMBIC Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹60 Cr | ₹58 Cr | ₹53 Cr | ₹51 Cr | ₹49 Cr | ₹39 Cr | ₹32 Cr | ₹37 Cr |
Expenses | ₹33 Cr | ₹32 Cr | ₹33 Cr | ₹30 Cr | ₹25 Cr | ₹28 Cr | ₹22 Cr | ₹26 Cr |
Operating Income | ₹27 Cr | ₹26 Cr | ₹20 Cr | ₹20 Cr | ₹24 Cr | ₹12 Cr | ₹10 Cr | ₹11 Cr |
Other Income | ₹3 Cr | ₹4 Cr | ₹66 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹48 Cr | ₹3 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹27 Cr | ₹27 Cr | ₹82 Cr | ₹19 Cr | ₹24 Cr | ₹11 Cr | ₹56 Cr | ₹12 Cr |
Profit After Tax | ₹24 Cr | ₹26 Cr | ₹77 Cr | ₹17 Cr | ₹21 Cr | ₹10 Cr | ₹52 Cr | ₹10 Cr |
EPS | ₹2.67 | ₹2.55 | ₹4.71 | ₹2.17 | ₹2.81 | ₹2.39 | ₹3.53 | ₹1.73 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALEMBIC | -2% | 4.3% | -2% |
SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -1.3% | 6.6% |
DIVIS LABORATORIES | 1.8% | 4.8% | 49.8% |
CIPLA | -1.1% | -1.3% | -1.4% |
TORRENT PHARMACEUTICALS | 0.6% | 4.2% | 15.1% |
DR REDDYS LABORATORIES | -1.8% | -6% | -1.6% |
MANKIND PHARMA | 6.9% | 6.2% | 13.7% |
ZYDUS LIFESCIENCES | -2.1% | -0.3% | -15.4% |
LUPIN | -2.2% | -4.7% | 8.6% |
ALEMBIC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.06 % |
Y-o-Y | 22.90 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹60 Cr | 4.06 | |
Dec2024 | ₹58 Cr | 9.47 | |
Sep2024 | ₹53 Cr | 4.19 | |
Jun2024 | ₹51 Cr | 3.55 | |
Mar2024 | ₹49 Cr | 24.72 | |
Dec2023 | ₹39 Cr | 21.81 | |
Sep2023 | ₹32 Cr | -12.38 | |
Jun2023 | ₹37 Cr | - |
ALEMBIC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 3.48 % |
Y-o-Y | 13.13 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹27 Cr | 3.48 | |
Dec2024 | ₹26 Cr | 34.90 | |
Sep2024 | ₹20 Cr | -4.07 | |
Jun2024 | ₹20 Cr | -15.53 | |
Mar2024 | ₹24 Cr | 106.76 | |
Dec2023 | ₹12 Cr | 15.07 | |
Sep2023 | ₹10 Cr | -6.62 | |
Jun2023 | ₹11 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.55 % |
Y-o-Y | -7.96 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 45.33% | -0.55 | |
Dec2024 | 45.58% | 23.22 | |
Sep2024 | 36.99% | -7.92 | |
Jun2024 | 40.17% | -18.44 | |
Mar2024 | 49.25% | 65.82 | |
Dec2023 | 29.7% | -5.53 | |
Sep2023 | 31.44% | 6.54 | |
Jun2023 | 29.51% | - |
ALEMBIC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -8.97 % |
Y-o-Y | 11.55 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹24 Cr | -8.97 | |
Dec2024 | ₹26 Cr | -66.25 | |
Sep2024 | ₹77 Cr | 343.80 | |
Jun2024 | ₹17 Cr | -18.18 | |
Mar2024 | ₹21 Cr | 114.62 | |
Dec2023 | ₹10 Cr | -80.82 | |
Sep2023 | ₹52 Cr | 419.18 | |
Jun2023 | ₹10 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -12.50 % |
Y-o-Y | -9.21 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 39.41 % | -12.50 | |
Dec2024 | 45.04 % | -69.18 | |
Sep2024 | 146.12 % | 326.01 | |
Jun2024 | 34.3 % | -20.99 | |
Mar2024 | 43.41 % | 72.06 | |
Dec2023 | 25.23 % | -84.25 | |
Sep2023 | 160.19 % | 492.42 | |
Jun2023 | 27.04 % | - |
ALEMBIC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 4.71 % |
Y-o-Y | -4.98 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.67 | 4.71 | |
Dec2024 | ₹2.55 | -45.86 | |
Sep2024 | ₹4.71 | 117.05 | |
Jun2024 | ₹2.17 | -22.78 | |
Mar2024 | ₹2.81 | 17.57 | |
Dec2023 | ₹2.39 | -32.29 | |
Sep2023 | ₹3.53 | 104.05 | |
Jun2023 | ₹1.73 | - |
You may also like the below Video Courses